Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
AK078587
|  |
AK078587 |
11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030411M21 product:unclassifiable, full insert sequence [AK078587] |
KLA | 1.37 |
1.28 |
1.13 |
1.06 |
1.15 |
1.31 |
1.22 |
| ATP | 1.04 |
1.08 |
1.21 |
1.22 |
1.27 |
1.12 |
1.14 |
| KLA/ATP | 1.48 |
1.66 |
1.97 |
1.26 |
1.17 |
1.03 |
1.28 |
|
Atox1 |  |
NM_009720 |
ATX1 (antioxidant protein 1) homolog 1 (yeast) (Atox1), mRNA [NM_009720] |
KLA | .85 |
.83 |
.92 |
.83 |
.78 |
.83 |
1.15 |
| ATP | 1.02 |
1.12 |
1.07 |
1.45 |
1.27 |
1.21 |
1.54 |
| KLA/ATP | .99 |
1.01 |
.93 |
1.23 |
1.11 |
1.14 |
1.73 |
|
Atp1a1 |  |
NM_144900 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide (Atp1a1), mRNA [NM_144900] |
KLA | .78 |
.94 |
.68 |
.81 |
.62 |
.55 |
.75 |
| ATP | 1.02 |
1.05 |
.86 |
.85 |
1.77 |
2.54 |
1.11 |
| KLA/ATP | .83 |
.99 |
.80 |
.75 |
.91 |
1.15 |
.68 |
|
Atp1a2 |  |
NM_178405 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide (Atp1a2), mRNA [NM_178405] |
KLA | 1.03 |
.98 |
1.03 |
1.05 |
1.03 |
.98 |
1.02 |
| ATP | 1.03 |
.98 |
1.06 |
1.05 |
1.05 |
.93 |
1.07 |
| KLA/ATP | 1.04 |
1.05 |
1.02 |
1.02 |
.98 |
.92 |
1.02 |
|
Atp1a3 |  |
AK053751 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130306P09 product:ATPase, Na+/K+ transporting, alpha 3 polypeptide, full insert sequence. [AK053751] |
KLA | .88 |
.87 |
.74 |
.80 |
.84 |
.88 |
.93 |
| ATP | .96 |
.83 |
.80 |
.88 |
.94 |
.89 |
1.15 |
| KLA/ATP | .89 |
.86 |
.79 |
.90 |
.93 |
.84 |
.92 |
|
Atp1a3 |  |
NM_144921 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide (Atp1a3), mRNA [NM_144921] |
KLA | .99 |
.87 |
.96 |
.86 |
.81 |
.61 |
.52 |
| ATP | 1.22 |
1.21 |
1.16 |
1.38 |
1.27 |
.92 |
1.30 |
| KLA/ATP | .96 |
1.10 |
1.17 |
1.42 |
1.11 |
.91 |
.93 |
|
Atp1b1 |  |
NM_009721 |
ATPase, Na+/K+ transporting, beta 1 polypeptide (Atp1b1), mRNA [NM_009721] |
KLA | .97 |
1.02 |
1.08 |
.98 |
.95 |
1.01 |
1.09 |
| ATP | 1.07 |
1.05 |
1.09 |
1.09 |
1.02 |
1.17 |
1.11 |
| KLA/ATP | .99 |
.99 |
.93 |
1.02 |
1.00 |
1.07 |
1.04 |
|
Atp1b2 |  |
NM_013415 |
ATPase, Na+/K+ transporting, beta 2 polypeptide (Atp1b2), mRNA [NM_013415] |
KLA | 1.18 |
1.09 |
1.11 |
1.12 |
1.16 |
1.12 |
1.15 |
| ATP | .95 |
.98 |
.99 |
1.26 |
1.06 |
1.10 |
1.07 |
| KLA/ATP | 1.15 |
1.16 |
1.09 |
1.19 |
1.27 |
1.13 |
1.02 |
|
Atp1b3 |  |
NM_007502 |
ATPase, Na+/K+ transporting, beta 3 polypeptide (Atp1b3), mRNA [NM_007502] |
KLA | 1.86 |
2.10 |
2.25 |
2.21 |
2.68 |
3.26 |
3.45 |
| ATP | 1.08 |
1.09 |
.93 |
1.13 |
1.55 |
2.14 |
2.38 |
| KLA/ATP | 1.95 |
2.10 |
1.84 |
2.34 |
2.20 |
2.96 |
4.69 |
|
Atp1b4 |  |
NM_133690 |
ATPase, (Na+)/K+ transporting, beta 4 polypeptide (Atp1b4), mRNA [NM_133690] |
KLA | .99 |
1.02 |
1.03 |
1.01 |
.95 |
.90 |
1.00 |
| ATP | 1.00 |
1.05 |
1.04 |
.98 |
1.07 |
.98 |
.97 |
| KLA/ATP | 1.00 |
1.05 |
1.03 |
1.04 |
.96 |
.97 |
1.01 |
|
Atp2b1 |  |
AK053569 |
0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130111D10 product:unclassifiable, full insert sequence. [AK053569] |
KLA | 1.18 |
1.02 |
.86 |
.87 |
.88 |
.99 |
.97 |
| ATP | 1.38 |
1.60 |
8.03 |
2.45 |
1.66 |
1.16 |
.94 |
| KLA/ATP | 1.32 |
1.41 |
6.67 |
1.98 |
1.15 |
1.08 |
.96 |
|
Atp2b1 |  |
AK161995 |
12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720440F18 product:Plasma membrane calcium pump isoform 1b (Fragment) homolog [Canis familiaris], full insert sequence. [AK16199 |
KLA | 1.64 |
1.50 |
1.23 |
1.02 |
.71 |
.75 |
.92 |
| ATP | 1.04 |
1.12 |
1.69 |
1.64 |
1.34 |
1.03 |
.66 |
| KLA/ATP | 1.69 |
1.58 |
2.20 |
1.99 |
1.03 |
.67 |
.57 |
|
Atp2b1 |  |
NM_026482 |
ATPase, Ca++ transporting, plasma membrane 1 (Atp2b1), mRNA [NM_026482] |
KLA | 1.91 |
1.76 |
1.64 |
1.21 |
.84 |
.79 |
1.07 |
| ATP | 1.00 |
1.01 |
1.43 |
2.32 |
2.28 |
1.71 |
1.06 |
| KLA/ATP | 1.86 |
1.85 |
2.23 |
2.48 |
1.71 |
1.05 |
1.04 |
|
Atp7a |  |
AK033254 |
15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030476D18 product:unclassifiable, full insert sequence. [AK033254] |
KLA | .91 |
.84 |
.84 |
.89 |
1.31 |
1.15 |
1.12 |
| ATP | 1.80 |
1.90 |
1.18 |
.84 |
1.39 |
1.31 |
1.27 |
| KLA/ATP | 1.35 |
1.64 |
1.55 |
.94 |
1.17 |
1.25 |
1.59 |
|
Atp7a |  |
NM_009726 |
ATPase, Cu++ transporting, alpha polypeptide (Atp7a), transcript variant 2, mRNA [NM_009726] |
KLA | .61 |
.61 |
.57 |
.69 |
.95 |
1.33 |
1.30 |
| ATP | 1.02 |
1.04 |
1.30 |
1.20 |
1.01 |
1.57 |
1.14 |
| KLA/ATP | .65 |
.64 |
.81 |
.78 |
.85 |
1.38 |
1.78 |
|
Clcn2 |  |
AF097415 |
chloride channel CLC-2 (Clcn2) mRNA, complete cds. [AF097415] |
KLA | 1.06 |
1.08 |
1.00 |
.89 |
.95 |
.93 |
1.03 |
| ATP | 1.00 |
1.03 |
1.19 |
1.02 |
.88 |
1.03 |
.96 |
| KLA/ATP | 1.05 |
1.07 |
1.23 |
.96 |
.91 |
.93 |
1.00 |
|
Clcn2 |  |
NM_009900 |
chloride channel 2 (Clcn2), mRNA [NM_009900] |
KLA | 1.02 |
.96 |
.95 |
.89 |
.92 |
.94 |
1.07 |
| ATP | 1.02 |
1.02 |
1.08 |
1.03 |
.95 |
1.03 |
1.01 |
| KLA/ATP | 1.09 |
.99 |
.99 |
.93 |
.98 |
.95 |
.99 |
|
Cybrd1 |  |
NM_028593 |
cytochrome b reductase 1 (Cybrd1), mRNA [NM_028593] |
KLA | 1.03 |
1.01 |
.96 |
.98 |
1.03 |
.99 |
.95 |
| ATP | 1.00 |
1.03 |
.98 |
.96 |
.98 |
1.04 |
.99 |
| KLA/ATP | .96 |
.95 |
.98 |
.96 |
1.04 |
.99 |
.99 |
|
Fth1 |  |
NM_010239 |
ferritin heavy chain 1 (Fth1), mRNA [NM_010239] |
KLA | .89 |
.88 |
.91 |
1.07 |
1.36 |
2.06 |
4.05 |
| ATP | .94 |
.88 |
.94 |
.85 |
1.27 |
2.56 |
3.84 |
| KLA/ATP | .80 |
.82 |
.97 |
.96 |
1.34 |
2.15 |
3.53 |
|
Ftl1 |  |
NM_010240 |
ferritin light chain 1 (Ftl1), mRNA [NM_010240] |
KLA | .63 |
.64 |
.56 |
.49 |
.54 |
.57 |
1.21 |
| ATP | 1.02 |
1.11 |
.77 |
1.09 |
1.00 |
1.01 |
1.89 |
| KLA/ATP | .65 |
.62 |
.41 |
.60 |
.60 |
.77 |
1.88 |
|
Ftmt |  |
NM_026286 |
ferritin mitochondrial (Ftmt), nuclear gene encoding mitochondrial protein, mRNA [NM_026286] |
KLA | 1.03 |
1.07 |
1.10 |
1.07 |
1.10 |
1.04 |
1.04 |
| ATP | 1.07 |
1.02 |
1.03 |
1.04 |
1.00 |
.99 |
1.02 |
| KLA/ATP | 1.07 |
1.09 |
1.14 |
1.04 |
1.04 |
1.08 |
1.05 |
|
Fxyd2 |  |
NM_052823 |
FXYD domain-containing ion transport regulator 2 (Fxyd2), transcript variant b, mRNA [NM_052823] |
KLA | 1.07 |
.97 |
1.09 |
.98 |
1.02 |
.96 |
.83 |
| ATP | 1.07 |
1.22 |
1.00 |
1.14 |
1.00 |
1.22 |
4.11 |
| KLA/ATP | 1.06 |
1.11 |
.96 |
1.13 |
.98 |
1.01 |
1.02 |
|
Heph |  |
NM_010417 |
hephaestin (Heph), transcript variant 1, mRNA [NM_010417] |
KLA | .98 |
.97 |
.93 |
1.01 |
.94 |
1.00 |
1.03 |
| ATP | 1.00 |
1.02 |
.99 |
.95 |
.94 |
1.01 |
1.13 |
| KLA/ATP | .97 |
.99 |
.99 |
.90 |
.96 |
1.00 |
.99 |
|
Heph |  |
NM_181273 |
hephaestin (Heph), transcript variant 2, mRNA [NM_181273] |
KLA | 1.11 |
.99 |
.97 |
.99 |
.97 |
.94 |
.93 |
| ATP | 1.00 |
.95 |
.93 |
.99 |
.96 |
.99 |
.99 |
| KLA/ATP | .97 |
.99 |
1.01 |
.98 |
1.00 |
.90 |
.97 |
|
Hmox1 |  |
NM_010442 |
heme oxygenase (decycling) 1 (Hmox1), mRNA [NM_010442] |
KLA | .30 |
.31 |
.32 |
.45 |
1.00 |
2.36 |
3.22 |
| ATP | .91 |
.98 |
.96 |
1.24 |
2.53 |
5.47 |
2.27 |
| KLA/ATP | .31 |
.30 |
.40 |
.87 |
2.26 |
4.40 |
3.94 |
|
Hmox2 |  |
NM_010443 |
heme oxygenase (decycling) 2 (Hmox2), mRNA [NM_010443] |
KLA | .75 |
.83 |
.93 |
1.06 |
1.45 |
1.79 |
1.39 |
| ATP | 1.14 |
1.17 |
.88 |
.88 |
.55 |
.72 |
1.76 |
| KLA/ATP | .90 |
.84 |
.71 |
.93 |
1.00 |
1.22 |
2.44 |
|
Mm.24508 4 |  |
144227202 |
Unknown |
KLA | 1.06 |
1.07 |
1.19 |
1.42 |
1.09 |
.83 |
.67 |
| ATP | .99 |
1.02 |
1.16 |
1.40 |
1.51 |
1.67 |
1.61 |
| KLA/ATP | 1.04 |
1.06 |
1.35 |
1.56 |
1.65 |
1.92 |
2.49 |
|
Mm.25237
|  |
141802859 |
Unknown |
KLA | 1.03 |
1.07 |
1.05 |
1.08 |
1.02 |
1.02 |
1.00 |
| ATP | .98 |
1.02 |
.89 |
.99 |
.99 |
1.03 |
1.09 |
| KLA/ATP | .92 |
.94 |
1.11 |
1.03 |
1.02 |
.97 |
1.09 |
|
Mt1 |  |
NM_013602 |
metallothionein 1 (Mt1), mRNA [NM_013602] |
KLA | 1.50 |
1.50 |
1.41 |
1.12 |
.91 |
.46 |
.33 |
| ATP | 1.06 |
1.19 |
1.27 |
1.89 |
2.04 |
2.56 |
.70 |
| KLA/ATP | 1.84 |
1.91 |
1.78 |
2.74 |
2.56 |
1.96 |
.38 |
|
Mt2 |  |
NM_008630 |
metallothionein 2 (Mt2), mRNA [NM_008630] |
KLA | 8.77 |
7.53 |
6.36 |
6.87 |
4.27 |
1.52 |
.25 |
| ATP | .87 |
.86 |
1.15 |
1.42 |
3.74 |
11.38 |
.82 |
| KLA/ATP | 8.06 |
8.80 |
9.96 |
10.06 |
8.80 |
6.34 |
.74 |
|
S100g |  |
NM_009789 |
S100 calcium binding protein G (S100g), mRNA [NM_009789] |
KLA | 1.04 |
1.07 |
1.01 |
1.03 |
1.08 |
1.00 |
1.00 |
| ATP | .98 |
1.05 |
1.01 |
.97 |
.99 |
1.03 |
1.03 |
| KLA/ATP | 1.00 |
1.04 |
.99 |
1.06 |
.98 |
.96 |
1.03 |
|
Slc11a1 |  |
NM_013612 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (Slc11a1), mRNA [NM_013612] |
KLA | .69 |
.70 |
.70 |
.66 |
.98 |
1.43 |
2.68 |
| ATP | .99 |
1.07 |
.84 |
.93 |
.97 |
1.65 |
3.01 |
| KLA/ATP | .75 |
.72 |
.54 |
.62 |
.61 |
1.42 |
4.71 |
|
Slc11a2 |  |
AK148276 |
B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370074D17 product:solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2, full insert sequence [AK148276] |
KLA | 4.68 |
4.47 |
5.11 |
5.84 |
7.80 |
4.69 |
3.36 |
| ATP | 1.10 |
1.31 |
1.75 |
2.78 |
4.90 |
3.41 |
2.70 |
| KLA/ATP | 4.73 |
4.82 |
5.48 |
5.26 |
3.72 |
3.15 |
3.67 |
|
Slc11a2 |  |
NM_008732 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 (Slc11a2), mRNA [NM_008732] |
KLA | 2.46 |
2.36 |
2.40 |
2.57 |
2.87 |
2.63 |
1.86 |
| ATP | 1.00 |
1.01 |
1.05 |
1.54 |
2.27 |
1.88 |
1.08 |
| KLA/ATP | 2.41 |
2.15 |
2.32 |
2.50 |
2.87 |
2.33 |
1.61 |
|
Slc26a3 |  |
AK035716 |
adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530095G06 product:solute carrier family 26, member 3, full insert sequence. [AK035716] |
KLA | .99 |
1.00 |
.99 |
1.02 |
.92 |
1.01 |
.99 |
| ATP | 1.04 |
1.05 |
.96 |
.99 |
.97 |
.98 |
1.28 |
| KLA/ATP | .97 |
1.07 |
.96 |
.99 |
.94 |
1.04 |
1.05 |
|
Slc26a3 |  |
NM_021353 |
solute carrier family 26, member 3 (Slc26a3), mRNA [NM_021353] |
KLA | 1.01 |
.98 |
1.00 |
1.02 |
.96 |
1.00 |
.96 |
| ATP | .99 |
.98 |
.96 |
.99 |
.99 |
1.01 |
.96 |
| KLA/ATP | 1.04 |
.99 |
1.04 |
.96 |
.98 |
.97 |
1.02 |
|
Slc26a6 |  |
NM_134420 |
solute carrier family 26, member 6 (Slc26a6), mRNA [NM_134420] |
KLA | .74 |
.72 |
.78 |
.75 |
.74 |
.71 |
.95 |
| ATP | .98 |
.88 |
.80 |
.75 |
.96 |
1.10 |
1.28 |
| KLA/ATP | .79 |
.78 |
.66 |
.64 |
.69 |
.78 |
1.06 |
|
Slc26a9 |  |
NM_177243 |
solute carrier family 26, member 9 (Slc26a9), mRNA [NM_177243] |
KLA | 1.02 |
1.07 |
1.11 |
1.11 |
1.19 |
1.08 |
1.04 |
| ATP | .97 |
1.02 |
1.11 |
1.17 |
1.21 |
1.04 |
1.38 |
| KLA/ATP | 1.09 |
1.04 |
1.13 |
1.07 |
1.14 |
1.14 |
1.98 |
|
Slc30a1 |  |
NM_009579 |
solute carrier family 30 (zinc transporter), member 1 (Slc30a1), mRNA [NM_009579] |
KLA | 2.36 |
2.66 |
2.68 |
2.27 |
2.06 |
2.83 |
1.34 |
| ATP | 1.03 |
1.00 |
.85 |
.71 |
1.96 |
4.54 |
2.24 |
| KLA/ATP | 2.38 |
2.48 |
2.18 |
3.64 |
12.19 |
10.74 |
3.35 |
|
Slc31a1 |  |
NM_175090 |
solute carrier family 31, member 1 (Slc31a1), mRNA [NM_175090] |
KLA | 1.96 |
2.07 |
2.30 |
2.36 |
3.09 |
4.15 |
3.13 |
| ATP | 1.14 |
1.16 |
1.14 |
1.25 |
2.49 |
3.13 |
1.94 |
| KLA/ATP | 2.10 |
2.18 |
2.24 |
2.49 |
2.96 |
3.08 |
4.07 |
|
Slc34a2 |  |
NM_011402 |
solute carrier family 34 (sodium phosphate), member 2 (Slc34a2), mRNA [NM_011402] |
KLA | .99 |
1.02 |
.99 |
1.03 |
1.00 |
1.04 |
1.07 |
| ATP | .98 |
1.03 |
1.01 |
1.06 |
1.02 |
1.03 |
1.00 |
| KLA/ATP | 1.05 |
1.01 |
1.05 |
1.04 |
1.06 |
1.04 |
.96 |
|
Slc39a4 |  |
NM_028064 |
solute carrier family 39 (zinc transporter), member 4 (Slc39a4), mRNA [NM_028064] |
KLA | 1.30 |
1.21 |
1.18 |
1.26 |
1.34 |
1.60 |
2.45 |
| ATP | .85 |
.71 |
.89 |
.82 |
1.47 |
5.69 |
4.50 |
| KLA/ATP | 1.03 |
1.05 |
1.20 |
.98 |
1.72 |
4.22 |
5.60 |
|
Slc40a1 |  |
NM_016917 |
solute carrier family 40 (iron-regulated transporter), member 1 (Slc40a1), mRNA [NM_016917] |
KLA | .10 |
.10 |
.08 |
.07 |
.07 |
.08 |
.10 |
| ATP | 1.02 |
.97 |
.99 |
.48 |
.53 |
2.17 |
.99 |
| KLA/ATP | .12 |
.09 |
.13 |
.11 |
.25 |
1.40 |
1.12 |
|
Slc46a1 |  |
NM_026740 |
solute carrier family 46, member 1 (Slc46a1), mRNA [NM_026740] |
KLA | .69 |
.70 |
.68 |
.63 |
.51 |
.55 |
.94 |
| ATP | .94 |
.99 |
1.24 |
1.13 |
.79 |
.49 |
2.42 |
| KLA/ATP | .68 |
.68 |
.78 |
.73 |
.60 |
.49 |
1.32 |
|
Slc5a1 |  |
NM_019810 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 (Slc5a1), mRNA [NM_019810] |
KLA | 1.02 |
1.02 |
1.03 |
1.04 |
.99 |
.93 |
1.06 |
| ATP | 1.03 |
1.03 |
1.02 |
1.05 |
1.04 |
.98 |
.97 |
| KLA/ATP | 1.02 |
.94 |
1.02 |
1.03 |
1.03 |
1.04 |
1.02 |
|
Slc6a19 |  |
NM_028878 |
solute carrier family 6 (neurotransmitter transporter), member 19 (Slc6a19), mRNA [NM_028878] |
KLA | 1.22 |
1.21 |
1.43 |
1.38 |
1.20 |
1.18 |
1.42 |
| ATP | 1.04 |
.97 |
.99 |
1.05 |
1.41 |
1.62 |
2.29 |
| KLA/ATP | 1.29 |
1.25 |
1.17 |
1.11 |
1.35 |
3.70 |
7.99 |
|
Slc8a1 |  |
AF004666 |
sodium-calcium exchanger (NCX1) mRNA, complete cds. [AF004666] |
KLA | 1.13 |
1.10 |
1.22 |
1.44 |
1.52 |
1.55 |
1.10 |
| ATP | 1.03 |
1.05 |
1.22 |
1.12 |
.65 |
.49 |
.67 |
| KLA/ATP | 1.04 |
1.21 |
1.30 |
1.44 |
.81 |
.63 |
1.01 |
|
Slc8a1 |  |
AF108396 |
sodium/calcium exchanger isoform NaCa3 (Ncx1) mRNA, partial cds. [AF108396] |
KLA | 1.07 |
1.18 |
1.30 |
1.22 |
1.31 |
1.39 |
1.21 |
| ATP | 1.03 |
1.02 |
1.10 |
1.07 |
.88 |
.91 |
1.23 |
| KLA/ATP | 1.15 |
1.17 |
1.14 |
1.22 |
.96 |
1.01 |
1.77 |
|
Slc8a1 |  |
NM_011406 |
solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), transcript variant A, mRNA [NM_011406] |
KLA | 1.12 |
1.16 |
1.22 |
1.25 |
1.35 |
1.33 |
1.11 |
| ATP | 1.03 |
1.04 |
1.07 |
1.10 |
.93 |
.90 |
1.19 |
| KLA/ATP | 1.13 |
1.24 |
1.19 |
1.16 |
.93 |
1.06 |
1.62 |
|
Slc9a3 |  |
AK033564 |
adult male colon cDNA, RIKEN full-length enriched library, clone:9030624O13 product:SODIUM [AK033564] |
KLA | .96 |
.94 |
.91 |
.97 |
.95 |
1.03 |
.99 |
| ATP | 1.06 |
1.02 |
1.01 |
.95 |
.90 |
.95 |
1.08 |
| KLA/ATP | .97 |
.91 |
.93 |
.95 |
1.02 |
1.03 |
1.01 |
|
Steap1 |  |
NM_027399 |
six transmembrane epithelial antigen of the prostate 1 (Steap1), mRNA [NM_027399] |
KLA | 1.05 |
.98 |
1.04 |
.95 |
.97 |
.99 |
.94 |
| ATP | 1.01 |
.97 |
1.04 |
1.09 |
.99 |
1.08 |
1.06 |
| KLA/ATP | .99 |
1.06 |
1.02 |
1.04 |
.96 |
.98 |
1.04 |
|
Steap2 |  |
NM_001103157 |
six transmembrane epithelial antigen of prostate 2 (Steap2), transcript variant 1, mRNA [NM_001103157] |
KLA | .98 |
.97 |
1.08 |
.98 |
1.03 |
1.05 |
1.03 |
| ATP | 1.01 |
1.04 |
1.04 |
1.02 |
1.00 |
.99 |
1.05 |
| KLA/ATP | 1.03 |
1.02 |
1.02 |
1.03 |
1.02 |
1.06 |
.98 |
|
Trf |  |
NM_133977 |
transferrin (Trf), mRNA [NM_133977] |
KLA | .84 |
.95 |
.94 |
.84 |
.74 |
.54 |
.20 |
| ATP | 1.02 |
1.05 |
.97 |
1.23 |
1.04 |
1.04 |
.63 |
| KLA/ATP | .94 |
.93 |
.88 |
1.07 |
.71 |
.77 |
.40 |
|
Trpm6 |  |
AK080899 |
4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430202L17 product:similar to CHANNEL-KINASE 2 [Homo sapiens], full insert sequence. [AK080899] |
KLA | 1.00 |
1.02 |
.95 |
1.02 |
.99 |
1.02 |
1.02 |
| ATP | .97 |
1.06 |
.87 |
.94 |
.96 |
1.09 |
1.03 |
| KLA/ATP | .98 |
.98 |
.98 |
1.00 |
.98 |
1.01 |
1.06 |
|
Trpm6 |  |
NM_153417 |
transient receptor potential cation channel, subfamily M, member 6 (Trpm6), mRNA [NM_153417] |
KLA | .98 |
.99 |
.97 |
1.00 |
1.02 |
1.10 |
1.04 |
| ATP | .97 |
1.03 |
1.05 |
1.07 |
1.03 |
1.06 |
.98 |
| KLA/ATP | .99 |
.94 |
.98 |
1.07 |
1.09 |
1.01 |
1.03 |
|
Trpm7 |  |
NM_021450 |
transient receptor potential cation channel, subfamily M, member 7 (Trpm7), mRNA [NM_021450] |
KLA | 1.36 |
1.31 |
1.34 |
.98 |
.92 |
.79 |
.72 |
| ATP | .95 |
.84 |
.64 |
.58 |
.94 |
.90 |
.74 |
| KLA/ATP | 1.36 |
1.23 |
.85 |
.84 |
1.07 |
.93 |
.70 |
|
Trpv6 |  |
NM_022413 |
transient receptor potential cation channel, subfamily V, member 6 (Trpv6), mRNA [NM_022413] |
KLA | .97 |
.96 |
1.01 |
1.01 |
.99 |
.96 |
1.03 |
| ATP | 1.04 |
.99 |
.96 |
.99 |
1.01 |
1.00 |
.80 |
| KLA/ATP | 1.06 |
.99 |
1.02 |
1.01 |
.97 |
.97 |
.99 |
|
Vdr |  |
NM_009504 |
vitamin D receptor (Vdr), mRNA [NM_009504] |
KLA | 1.01 |
1.01 |
1.12 |
1.12 |
1.09 |
.96 |
.94 |
| ATP | .99 |
1.03 |
1.09 |
1.19 |
1.25 |
1.24 |
1.36 |
| KLA/ATP | .99 |
1.03 |
1.03 |
1.28 |
1.21 |
1.42 |
1.76 |
|